¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"paradoxical pupillary reaction"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
  • indophenol reaction
    ÀεµÆä³î°Ë»ç
  • induced reaction
    À¯¹ß¹ÝÀÀ
  • inhibition reaction
    ¾ïÁ¦¹ÝÀÀ
  • interface reaction
    °æ°è¸é¹ÝÀÀ
  • intermediate reaction
    Áß°£¹ÝÀÀ
  • intermicellar reaction
    ¹Ì¼¼¸£°£¹ÝÀÀ
  • Jarisch-Herxheimer reaction
    ¾ß¸®½´-Ç츣ũ½ºÇÏÀ̸ӹÝÀÀ
  • johnin reaction
    ¿ä´Ñ¹ÝÀÀ
  • labile oxidase reaction
    ºÒ¾ÈÁ¤»êÈ­È¿¼Ò¹ÝÀÀ
  • lengthening reaction
    1. ´ÃÀÓ¹ÝÀÀ, ½ÅÀå¹ÝÀÀ 2. ±Ù´ÃÀÓ¹ÝÀÀ
  • lepra reaction
    ³ªº´¹ÝÀÀ
  • lepromin reaction
    ·¹ÇÁ·Î¹Î¹ÝÀÀ
  • leukemoid reaction
    ¹éÇ÷º´¸ð¾ç¹ÝÀÀ
  • leukoerythroblastic reaction
    ¹éÀûÇ÷¸ð±¸¹ÝÀÀ
  • labyrinthine righting reaction
    ¹Ì·Î¹Ù·ÎÀâ±â¹ÝÀÀ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
  • humoral reaction
    ü¾×¹ÝÀÀ
  • hyperkinetic reaction
    °ú´Ù¿îµ¿¹ÝÀÀ
  • hypersensitivity reaction
    °ú¹Î¹ÝÀÀ
  • hypnic reaction
    ¼ö¸é¹ÝÀÀ
  • hysteric reaction
    È÷½ºÅ׸®¹ÝÀÀ
  • id reaction
    ¼ÓÁø¹ÝÀÀ
  • immune reaction
    ¸é¿ª¹ÝÀÀ
  • immune adherence reaction
    ¸é¿ªºÎÂø¹ÝÀÀ
  • immunologic reaction
    (¢¡immune) ¸é¿ª¹ÝÀÀ
  • immunological reaction
    (¢¡immune) ¸é¿ª¹ÝÀÀ
  • immunoprecipitin reaction
    ¸é¿ªÄ§Àü¹ÝÀÀ
  • indirect immunofluorescence reaction
    °£Á¢¸é¿ªÇü±¤¹ÝÀÀ
  • indophenol reaction
    (¢¡indophenol test) ÀεµÆä³î°Ë»ç
  • induced reaction
    À¯¹ß¹ÝÀÀ
  • inhibition reaction
    ¾ïÁ¦¹ÝÀÀ, ÀúÁö¹ÝÀÀ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
  • psychotic depressive reaction
    Á¤½ÅÁõÀû ¿ì¿ï¹ÝÀÀ(éØê¦Úãëë).
  • pyrogenic reaction
    ¹ß¿­¹ÝÀÀ.
  • pyrogenic reaction
    ¹ß¿­¹ÝÀÀ(Û¡æðÚãëë)
  • pyrrole reaction
    ÇǷѹÝÀÀ(¡­Úãëë).
  • quellung reaction
    ÆØÃ¢¹ÝÀÀ(ø³óìÚãëë).
  • rage reaction
    ³ë¹ÝÀÀ(ÖÍÚãëë).
  • rate limiting reaction
    ¼ÓµµÁ¦ÇѹÝÀÀ.
  • reaction accelerator
    ¹ÝÀÀÃËÁøÃ¼(Úãëë õµòäô÷).
  • reaction center
    Ȱ¼ºÁß½É(üÀàõñéãý).
  • reaction deficiency
    ¹ÝÀÀ°áÇÌ
  • reaction fever
    ¹ÝÀÀ¿­(Úãëëæð).
  • reaction formation
    ¹ÝÀÀÇü¼º(Úãëëû¡à÷).(Á¤½Å)¹Ýµ¿Çü¼º(ÚãÔÑû¡à÷).
  • reaction isochore
    ¹ÝÀÀÇ׿ë½Ä(ÚãëëùöéÄãÒ).
  • reaction kinetics
    ¹ÝÀÀ¼Óµµ·Ð(ÚãëëáÜöôÖå).
  • reaction of identity
    ÀÏÄ¡¹ÝÀÀ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
  • cytotoxic reaction
    µ¶¼º¹ÝÀÀ.
  • cytotoxic reaction
    ¼¼Æ÷ µ¶¼º ¹ÝÀÀ
  • defensive reaction
    ¹æ¾îÀÛ¿ë(ÛÁåÝíÂéÄ)
  • deficient release reaction
    ¹æÃâ¹ÝÀÀ°áÇÌ.
  • delayed allergic reaction
    Áö¿¬¼º ¾Ë·¹¸£±â¹ÝÀÀ.
  • delayed allergic reaction
    Áö¿¬¼º ¾Ë·¹¸£±â¹ÝÀÀ
  • delayed cell-mediated reaction
    Áö¿¬Çü ¼¼Æ÷¸Å°³¹ÝÀÀ
  • delayed reaction
    Áö¿¬¹ÝÀÀ(òÀæÅÚãëë).
  • desmoid reaction
    Àδë¾ç¹ÝÀÀ(ìåÓáåÆÚãëë).
  • diacetyl reaction
    µð¾Æ¼¼Æ¿¹ÝÀÀ
  • diazo reaction
    µð¾ÆÁ¶¹ÝÀÀ
  • diazo reaction
    µð¾ÆÁ¶¹ÝÀÀ.
  • dissociative reaction
    ÇØ¸®¼º ¹ÝÀÀ(ú°ìÆàõÚãëë).
  • donor reaction
    °øÇ÷ÀÚ¹ÝÀÀ
  • dopa reaction
    µµÆÄ ¹ÝÀÀ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 12
DSHR delayed skin hypersensitivity reaction
Ea R reaction of degeneration [Ger. Entartungs-Reaktion]
E-E erythema-edema [reaction]
FRO floor reaction orthosis
GHR granulomatous hypersensitivity reaction
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 12
Q/C PCR Quantitative competitive polymerase chain reaction
QRT-PCR Quantitative reverse transcriptase-polymerase chain reaction
QRT-PCR Quantitative reverse transcription polymerase chain reaction
PCR RT)--polymerase chain reaction
RAPD-PCR Random Amplified Polymorphic DNA-Polymerase Chain Reaction
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 12
myelocytic leukemoid reaction Leukocytosis of at least moderate degree, e.g., 50,000 or more per cu mm, with a few immature forms, e.g., 1 or 2% myelocytes, but chiefly mature polymorphonuclear leukocytes in the circulating blood; may be observed in association with tuberculosis, chronic osteomyelitis, various types of empyema, malaria, pneumococcal pneumonia, meningococcal meningitis, Hodgkin's disease, and metastases of carcinoma in the bone marrow.
(05 Mar 2000)
coupled reaction Two chemical reactions that share a common intermediate (for example, the productof the first reaction is a reactant in the second) and therefore havesome kind of energy exchange between them.
(09 Oct 1997)
Porter-Silber reaction The basis of the 17-hydroxycorticosteroid test; C-21 adrenocorticosteroids, which contain a dihydroxyacetone group at carbons 19, 20, and 21, react with phenylhydrazine.
(05 Mar 2000)
Haber-Weiss reaction The reaction of superoxide (O2-- with hydrogen peroxide to produce molecular oxygen (O2), hydroxide radical (OH-), and OH-; often, iron catalyzed; a source of oxidative stress in blood cells and various tissues.
(05 Mar 2000)
cross reaction <haematology, immunology> Serological reactions in which an antiserum against one antigen reacts with a non-identical but closely related antigen.
(12 Dec 1998)
haemoclastic reaction Haemolysis as observed in the laking of the blood.
(05 Mar 2000)
cutaneous graft versus host reaction An acute erythematous maculopapular reaction with bulla formation in the most severe cases; chronic changes may resemble lichen planus or scleroderma.
(05 Mar 2000)
cutaneous reaction The inflammatory reaction in the case of a skin test in a sensitive (allergic) subject.
Synonym: cutaneous reaction.
Origin: L. Cutis, skin, + reaction
(05 Mar 2000)
Prausnitz-Kustner reaction A test for the presence of immediate hypersensitivity in humans; test serum from an atopic individual is injected intradermally into a normal subject; the normal subject is challenged 24-48 hours later with the antigen suspected of causing the immediate hypersensitivity reaction in the atopic individual.
Synonym: P-K test.
(05 Mar 2000)
precipitin reaction See: precipitin, precipitin test.
(05 Mar 2000)
harlequin reaction Sudden blanching of the lower half of the body of an infant lying on its side, leaving the remaining half of the body the normal pink colour.
(05 Mar 2000)
cytotoxic reaction An immunologic (allergic) reaction in which noncytotropic IgG or IgM antibody combines with specific antigen on cell surfaces; the resulting complex initiates the activation of complement which causes cell lysis or other damage, or which, in the absence of complement, may lead to phagocytosis or may enhance T lymphocyte involvement.
(05 Mar 2000)
primary reaction <dermatology> The cutaneous and sometimes systemic reactions associated with vaccination with smallpox vaccine.
(18 Nov 1997)
Sakaguchi reaction Guanidines in alkaline solution develop an intense red colour when treated with alpha-naphthol and sodium hypochlorite; a qualitative test for arginine, free or in a protein.
(05 Mar 2000)
Henle's reaction Dark brown staining of the medullary cells of the adrenal bodies when treated with the salts of chromium, the cortical cells remaining unstained.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 12
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 12
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 12
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 12
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 12
ÅëÇÕ°Ë»ö ¿Ï·á